"Dana-Farber Cancer Institute, Inc., Bristol Myers Squibb Co., and Ono PharmaceuticalCo., Ltd. have entered into a global agreement to settle all disputes relating to the Honjo-Freeman Patents. Under the agreement, Bristol Myers Squibb and Ono will make a lump-sum payment to Dana-Farber, with the possibility of additional payments in the future.
All other terms of the agreement are confidential. This resolution paves the way for our continued focus on pioneering discoveries that have enabled cancer immunotherapies and advances our shared goal to provide extraordinary care for ourpatients."
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
